<img height="1" width="1" style="display:none" src="https://q.quora.com/_/ad/1ac644d4c3f54087bef4289a089c9d7c/pixel?tag=ViewContent&amp;noscript=1">

Sermonix Pharmaceuticals Closes US $26 Million Series A Financing Round Led By WILD Family Office

July 31, 2019|

SFO MFO

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female-specific oncology products, today announced the completion of a US$26 million Series A financing. The round was led by the WILD Family Office, which manages the investments of entrepreneur Hans-Peter Wild.

Read the full story on Yahoo! Finance here.

YOU MAY ALSO BE INTERESTED IN:

About FINTRX

The FINTRX Platform is the leading family office data, research, and intelligence platform to the alternative investment industry & private capital markets. Leveraging their intuitive user interface, coupled with the largest and most comprehensive family office research tool, FINTRX continues to raise the bar for asset raising solutions.

2019 Family Office Guide | FINTRX

featured Post

What Is a Family Office?   Let's start with the basics. The true definition of a family office is defined as a group that provides a family (or ...
Sofia is an employment lawyer, who advises ultra-high-net-worth clients on private staffing and a wide range of other issues. She advises on ...
Darragh heads up DOS & Co., the London Virtual Family Office which caters for wealthy families and individuals who have operations, properties or ...